Skip to main content
. 2022 Nov 24;5:100175. doi: 10.1016/j.jtauto.2022.100175

Table 2.

Comparison of anti-RNP-A, anti-N IgG and neutralizing antibody levels among COVID-19 patients requiring ICU and non-ICU care and RNP-A positive and negative patient cohorts.

Cohort N RNP-A (AI) anti-N IgG (U/mL) Nab inhibition (%)
ICU 41 1.2 1044.0 87.1%
non-ICU 78 0.4 192.8 58.6%
p value 0.0006 0.0002 <0.0001
RNP-A + 21 NA 1609.9 83.2%
RNP-A - 98 NA 234.0 63.2%
p value NA <0.0001 0.0031

t-test, p value < 0.05, significant difference.